September 29, 2016 7:58 PM ET

Biotechnology

Company Overview of LiRIS Biomedical, Inc.

Key Executives for LiRIS Biomedical, Inc.

NameBoard RelationshipsTitleAge
Purnanand Duddu Sarma Ph.D.8 RelationshipsChief Executive Officer, President and Director--
Michael J. Cima Ph.D.47 RelationshipsCo-Founder, Scientific Advisor and Director56
Robert S. Langer Jr., Ph.D., Sc.D.520 RelationshipsCo-Founder, Scientific Advisor and Director67
Diane Marcou No RelationshipsChief Financial Officer--
Christopher J. Searcy Pharm.D.5 RelationshipsChief Business Officer and Senior Vice President--

LiRIS Biomedical, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Purnanand Duddu Sarma Ph.D. 8 RelationshipsLiRIS Biomedical, Inc.--
Michael J. Cima Ph.D. 47 RelationshipsT2 Biosystems, Inc.56
Robert S. Langer Jr., Ph.D., Sc.D. 520 RelationshipsPureTech Health plc67
Edwin M. Kania Jr. 95 RelationshipsFlagship Ventures58
Kevin J. Bitterman Ph.D. 83 RelationshipsPolaris Partners40
View All Board Members

LiRIS Biomedical, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
383.1K
Bonus
264.0K
Total Short Term Compensation
478.4K
Total Value of Options
32.9M
Compensation as of Fiscal Year
LiRIS Biomedical, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Factor Therapeutics Limited Appoints Melanie Farris AGIA as Company Secretary ,Effective September 29, 2016
September 28, 2016 10:30 PM ET
Medivation, Inc. Repays Outstanding Amounts Due in Connection with the Amended and Restated Credit Agreement, Dated as of October 23, 2015; Announces Board Changes
September 28, 2016 1:02 PM ET
Proteostasis Therapeutics Inc. Announces Board Appointments
September 28, 2016 11:30 AM ET
Bavarian Nordic A/S Appoints Dr. Christopher R. Heery as Chief Medical Officer
September 28, 2016 11:00 AM ET
China Regenerative Medicine International Limited Management Changes
September 28, 2016 9:34 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LiRIS Biomedical, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.